EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CGRP–RAMP1/CALCRL Signaling Drives TGF-β2-Mediated Immune Evasion and Pancreatic Cancer Progression

Biyu Zhang, Yaxin Li, Simiao Fan iD, Jiamei Zhang, Yu Zhang, Wen Wang, Liang Luo, Wanying Xiao, Xinlei Xie iD, Xiaoxiao Jian, Qiuying Han, Shaoyi Huang iD und 6 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27209108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Biyu Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Nanhu Laboratory, State Key Laboratory of Biomedical Analysis (SKLBA, Formerly Known as National Center of Biomedical Analysis), Beijing 100039, Chin…. Hauptthemen laut MEDLINE: Receptor Activity-Modifying Protein 1, Calcitonin Gene-Related Peptide, Pancreatic Neoplasms, Signal Transduction. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive neural remodeling and a profoundly immunosuppressive tumor microenvironment, both of which contribute to disease progression and therapeutic resistance. However, whether nociceptor-derived signals directly reprogram PDAC cells to promote immune evasion remains poorly understood. Here, we identify a previously unrecognized tumor-intrinsic neuroimmune mechanism driven by calcitonin gene-related peptide (CGRP) signaling through the receptor complex RAMP1/CALCRL on PDAC cells. CRISPR/Cas9-mediated deletion of Ramp1 or Calcrl did not alter PDAC cell proliferation in vitro but markedly suppressed tumor growth and prolonged survival in immunocompetent mice. These antitumor effects were lost in immunodeficient hosts, indicating that the pro-tumorigenic function of CGRP signaling depends on an intact host immune system. Consistently, tumor cell-specific loss of Ramp1 or Calcrl remodeled the tumor immune microenvironment, enhancing CD4+ and CD8+ T-cell effector activity. Mechanistically, CGRP stimulation promoted TGF-β2 expression and secretion by PDAC cells in a RAMP1-dependent manner. Tumor-derived TGF-β2 subsequently acted in a paracrine fashion to suppress CD8+ T-cell activation and cytotoxic function, whereas genetic disruption of RAMP1 or pharmacological inhibition of TGF-β signaling relieved this immunosuppression. Together, these findings define a CGRP–RAMP1/CALCRL–TGF-β2 signaling axis through which nociceptive input is converted into tumor-driven adaptive immune evasion in PDAC. This pathway reveals a previously underappreciated mechanism linking neural signaling to PDAC progression and identifies CGRP receptor signaling as a potential therapeutic vulnerability for restoring antitumor immunity and improving the responsiveness of PDAC to immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor Activity-Modifying Protein 1Calcitonin Gene-Related PeptidePancreatic NeoplasmsSignal TransductionCalcitonin Receptor-Like ProteinTransforming Growth Factor beta2Carcinoma, Pancreatic DuctalTumor EscapeAnimalsHumansMiceTumor MicroenvironmentCell Line, TumorDisease Progression

Stichwörter der Autor:innen

CALCRLCGRPPDACRAMP1T cellTGF-βmechanism

Substanzen

Receptor Activity-Modifying Protein 1Calcitonin Gene-Related PeptideCalcitonin Receptor-Like ProteinTransforming Growth Factor beta2RAMP1 protein, humanCALCRL protein, human

Autor:innen und Institutionen

  • Nanhu Laboratory, State Key Laboratory of Biomedical Analysis (SKLBA, Formerly Known as National Center of Biomedical Analysis), Beijing 100039, China.
  • School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.

ORCID-Profile: Simiao Fan, Xinlei Xie, Shaoyi Huang, Min Wu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, B., Li, Y., Fan, S., Zhang, J., Zhang, Y., Wang, W., Luo, L., Xiao, W., Xie, X., Jian, X., Han, Q., Huang, S., Wu, M., Song, Z., Wen, Y., Tu, H., Li, S., & Hu, H. (2026). CGRP–RAMP1/CALCRL Signaling Drives TGF-β2-Mediated Immune Evasion and Pancreatic Cancer Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209108

Vancouver

Zhang B, Li Y, Fan S, Zhang J, Zhang Y, Wang W, et al. CGRP–RAMP1/CALCRL Signaling Drives TGF-β2-Mediated Immune Evasion and Pancreatic Cancer Progression. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209108

BibTeX
@article{Zhang2026,
  author = {Zhang, Biyu and Li, Yaxin and Fan, Simiao and Zhang, Jiamei and Zhang, Yu and Wang, Wen and Luo, Liang and Xiao, Wanying and Xie, Xinlei and Jian, Xiaoxiao and Han, Qiuying and Huang, Shaoyi and Wu, Min and Song, Zengqing and Wen, Yuqi and Tu, Haiqing and Li, Sen and Hu, Huaibin},
  title = {CGRP–RAMP1/CALCRL Signaling Drives TGF-β2-Mediated Immune Evasion and Pancreatic Cancer Progression},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27209108}
}
Kostenlos starten →